Law & Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Law & Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Braunschweig City Clinical Center
Impalpable prostate tumors should be graded T1c regardless of TRUS visibility
June 26th, 2004
Impalpable prostate tumors should be graded T1c regardless of TRUS visibility. "Since 1992, the TNM system has classified impalpable prostate cancers with visible lesions on imaging as clinical stage T2. Due to controversial reports in the literature, this classification has not been well accepted in clinical practice. Most urologists consider all impalpable prostate cancers irrespective of their imaging as T1c," researchers in Germany report. "Transrectal ultrasound (TRUS) is the imaging tool most frequently used for diagnostic purposes in prostatic diseases. In our study, we compared prognostic cancer characteristics and the likelihood of...
Source: Law & Health Weekly (2004-06-26)
|
